682 related articles for article (PubMed ID: 10733261)
21. Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine.
Fong D; Kaiser A; Spizzo G; Gastl G; Tzankov A
Br J Haematol; 2005 Apr; 129(2):199-205. PubMed ID: 15813847
[TBL] [Abstract][Full Text] [Related]
22. The rate of in vitro fludarabine-induced peripheral blood and bone marrow cell apoptosis may predict the chemotherapy outcome in patients with chronic lymphocytic leukemia.
Podhorecka M; Klimek P; Chocholska S; Szymczyk A; Macheta A; Kowal M; Dmoszynska A; Hus M
Eur J Clin Pharmacol; 2015 Sep; 71(9):1121-7. PubMed ID: 26141594
[TBL] [Abstract][Full Text] [Related]
23. What is the optimal initial treatment for chronic lymphocytic leukemia?
Lin TS
Oncology (Williston Park); 2007 Dec; 21(14):1641-9; discussion 1649-54, 1659, 1662. PubMed ID: 18247015
[TBL] [Abstract][Full Text] [Related]
24. Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011.
Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Martell RE; Larson RA; Schiffer CA
J Clin Oncol; 2001 Aug; 19(16):3611-21. PubMed ID: 11504743
[TBL] [Abstract][Full Text] [Related]
25. Management of chronic lymphocytic leukemia.
Han T; Rai KR
Hematol Oncol Clin North Am; 1990 Apr; 4(2):431-45. PubMed ID: 2182600
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia.
Montillo M; Tedeschi A; O'Brien S; Di Raimondo F; Lerner S; Ferrajoli A; Morra E; Keating MJ
Cancer; 2003 Jan; 97(1):114-20. PubMed ID: 12491512
[TBL] [Abstract][Full Text] [Related]
27. [Prolymphocytic leukemia: the therapeutic strategy].
Fava S; De Paoli A; Grimi E; Luoni M; Tocci A; Tosi A; Cassi E
Recenti Prog Med; 1994 Oct; 85(10):496-501. PubMed ID: 7809465
[TBL] [Abstract][Full Text] [Related]
28. Clinical experience with fludarabine in leukaemia.
Keating MJ; Estey E; O'Brien S; Kantarjian H; Robertson LE; Plunkett W
Drugs; 1994; 47 Suppl 6():39-49. PubMed ID: 7525188
[TBL] [Abstract][Full Text] [Related]
29. Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.
Ural AU; Kubar A; Avcu F; Tastan HB; Safali M; Nevruz O; Cetin T
Clin Exp Dermatol; 2007 Mar; 32(2):151-4. PubMed ID: 17244344
[TBL] [Abstract][Full Text] [Related]
30. B-CLL in PLL transformation associated with hypercalcemia.
Lerner D; Esteves C; De Oliveira MS
Leuk Lymphoma; 1994 Jan; 12(3-4):321-5. PubMed ID: 8167564
[TBL] [Abstract][Full Text] [Related]
31. Chlorambucil plus theophylline vs chlorambucil alone as a front line therapy for B-cell chronic lymphatic leukemia.
Mabed M; Aref S; Fouda M; El-Sharawy S
Leuk Lymphoma; 2004 Oct; 45(10):2029-35. PubMed ID: 15370247
[TBL] [Abstract][Full Text] [Related]
32. Chronic lymphocytic leukemia.
Byrd JC; Stilgenbauer S; Flinn IW
Hematology Am Soc Hematol Educ Program; 2004; ():163-83. PubMed ID: 15561682
[TBL] [Abstract][Full Text] [Related]
33. The clinical and epidemiological burden of chronic lymphocytic leukaemia.
Redaelli A; Laskin BL; Stephens JM; Botteman MF; Pashos CL
Eur J Cancer Care (Engl); 2004 Jul; 13(3):279-87. PubMed ID: 15196232
[TBL] [Abstract][Full Text] [Related]
34. [Chronic lymphocytic leukemia--the old and the new].
Korte W; Cogliatti S
Ther Umsch; 2004 Feb; 61(2):151-6. PubMed ID: 15018398
[TBL] [Abstract][Full Text] [Related]
35. Fludarabine versus chlorambucil: is the debate over?
Rai KR; Hollweg A
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S7-9. PubMed ID: 22035752
[TBL] [Abstract][Full Text] [Related]
36. Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment.
Hallek M
Am J Hematol; 2013 Sep; 88(9):803-16. PubMed ID: 23720127
[TBL] [Abstract][Full Text] [Related]
37. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment.
Hallek M
Am J Hematol; 2015 May; 90(5):446-60. PubMed ID: 25908509
[TBL] [Abstract][Full Text] [Related]
38. Progress in CLL, chemotherapy, antibodies and transplantation.
Keating MJ
Biomed Pharmacother; 2001 Nov; 55(9-10):524-8. PubMed ID: 11769960
[TBL] [Abstract][Full Text] [Related]
39. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
[TBL] [Abstract][Full Text] [Related]
40. Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL)-a single region experience on consecutive patients.
Eketorp Sylvan S; Lundin J; Ipek M; Palma M; Karlsson C; Hansson L
Ann Hematol; 2014 Oct; 93(10):1725-33. PubMed ID: 24844780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
